JAMIE MACKNET: Open Payments
NPI 1427177518 · LOMA LINDA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,731 in 62 payments from 14 companies in 2025. Trend: 2023 $2,782 · 2024 $1,258 · 2025 $1,731
Food & beverage: $1,731
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 19 | $316 |
| Regeneron Healthcare Solutions, Inc. | 3 | $303 |
| ABBVIE INC. | 10 | $296 |
| Galderma Laboratories, L.P. | 2 | $233 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $124 |
| RECORDATI_RARE_DISEASES_INC. | 4 | $88 |
| Corcept Therapeutics | 3 | $86 |
| Lilly USA, LLC | 4 | $79 |
| Novartis Pharmaceuticals Corporation | 4 | $79 |
| Novo Nordisk Inc | 2 | $39 |
Products named: FREESTYLE LIBRE 3, NEMLUVIO, LIBTAYO, SKYRIZI, JARDIANCE, DUPIXENT, ISTURISA, Korlym.
Industry payments across CA — which companies pay providers there.
